Clinical Trials Directory

Trials / Completed

CompletedNCT01192360

Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
16 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine if quantitative Dynamic contrast-enhanced magnetic resonance (DCE MR) perfusion imaging accurately quantifies right and left pulmonary artery blood flow as compared with phase contrast flow velocity mapping (PC), the current gold standard of flow volume measurements.

Detailed description

Many conditions of the heart or the lungs lead to differences in how the blood is pumped to the lungs. Specifically, some areas of the lung may receive less blood supply than others. We would like to do a research study in children and adolescents who have a heart condition or a chronic or stable lung condition. We are doing this study to see if measuring the circulation of blood in the lungs in children is possible using magnetic resonance imaging (MRI) with a special dye (contrast medium) injection called Magnevist®.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhase contrast flow velocity mapping (PC)An MRI is done using the phase contrast flow velocity mapping (PC)technique. Using PC, an imaging slice is prescribed perpendicular to the vessel's course. Within the pulmonary circulation, PC can quantify total pulmonary blood flow and the right / left distribution of the lung blood flow volume.
PROCEDUREDynamic contrast-enhanced magnetic resonance imagingDynamic contrast-enhanced magnetic resonance (DCE MR) perfusion imaging imaging is a non-invasive method to quantify regional pulmonary blood flow. A bolus of gadolinium-containing contrast medium is injected and its passage through the pulmonary circulation traced using a repetitive rapid three-dimensional (3D) T1 weighted angiography sequence.

Timeline

Start date
2010-09-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-09-01
Last updated
2019-07-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01192360. Inclusion in this directory is not an endorsement.